Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Companies
Recent news which mentions Companies
< Previous
1
2
3
4
5
6
7
8
9
...
30
31
Next >
Vaccine stocks fall as Senate panel advances RFK Jr.'s nomination for HHS secretary
February 04, 2025
Tags
Health & Science
Moderna Inc
GSK plc
From
CNBC.com News
Pfizer tops earnings estimates as Covid product sales beat expectations and cost cuts pay off
February 04, 2025
Tags
US: News
Companies
Biotech and Pharmaceuticals
From
CNBC.com News
Merck's 2025 revenue outlook falls short as it pauses Gardasil vaccine shipments to China
February 04, 2025
Tags
Business
Pharmaceuticals
Earnings
From
CNBC.com News
These may be the best companies to work for in a DEI crisis moment for America
February 03, 2025
Tickers
JOBS
Tags
Trane Technologies PLC
Union Pacific Corp
CNBC Global CFO Council
From
CNBC.com News
Trump tariffs could raise medication costs and exacerbate shortages, drug trade groups warn
February 03, 2025
Tags
Companies
Biotech and Pharmaceuticals
Trade
From
CNBC.com News
The 2025 Just 100 rankings
February 03, 2025
Tags
stocks
Just 100
Leadership
From
CNBC.com News
FDA approves Vertex’s non-opioid painkiller, first new kind of pain medicine in decades
January 30, 2025
Tags
Science
Vertex Pharmaceuticals Inc
Health & Science
From
CNBC.com News
RFK Jr. appears unfamiliar with basics of Medicare, Medicaid during Senate confirmation hearings
January 30, 2025
Tags
Biotechnology
Social issues
Health & Science
From
CNBC.com News
Watch live: RFK Jr. testifies at Senate confirmation hearing for HHS secretary
January 29, 2025
Tags
Business
Health care industry
Pharmaceuticals
From
CNBC.com News
FDA approves Novo Nordisk’s diabetes drug Ozempic for chronic kidney disease, expanding its use
January 28, 2025
Tags
Health & Science
Novo Nordisk A/S
Biotechnology
From
CNBC.com News
Chinese AI applications now have bigger aims — they're looking beyond chatbots
January 26, 2025
Tags
China Markets
China Economy
Stock markets
From
CNBC.com News
Pharma is hopeful about Trump's second term — here's what to expect for drugmakers
January 26, 2025
Tags
Health & Science
GSK plc
Pfizer Inc
From
CNBC.com News
UnitedHealthcare taps company veteran Tim Noel as new CEO following Brian Thompson killing
January 23, 2025
Tags
UnitedHealth Group Inc
Health & Science
Social issues
From
CNBC.com News
He bought an abandoned tin mine in Phuket in 1984. Now, his hotel chain is worth over $200 million
January 22, 2025
Tags
Entrepreneurship
Make It / Power Players
Hospitality and leisure industry
From
CNBC.com News
FDA approves Johnson & Johnson’s nasal spray for depression as standalone treatment
January 21, 2025
Tags
Business
Pharmaceuticals
Health & Science
From
CNBC.com News
Costco union representing 18,000 workers authorize nationwide strike
January 20, 2025
Tags
Labor economy
Companies
Markets
From
CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
January 17, 2025
Tags
Business
Health care industry
Pharmaceuticals
From
CNBC.com News
Medicare's new $2,000 cap on out-of-pocket drug costs could save enrollees thousands, AARP says
January 16, 2025
Tags
Social issues
Health & Science
Prescription drug costs
From
CNBC.com News
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
January 15, 2025
Tags
Health & Science
Bristol/Myers Squibb Co
Biotechnology
From
CNBC.com News
UK antitrust regulator opens probe into Google's search services
January 14, 2025
Tags
US: News
Breaking news
Technology
From
CNBC.com News
China's electric car boom is expected to slow down in 2025
January 13, 2025
Tags
Tesla Inc
stocks
Autos
From
CNBC.com News
Moderna stock plunges 18% after company lowers 2025 sales forecast by $1 billion
January 13, 2025
Tags
Moderna Inc
Biotechnology
Sanofi SA
From
CNBC.com News
Walgreens results top estimates as drugstore chain works to slash costs
January 10, 2025
Tags
Health care industry
Earnings
Pharmaceuticals
From
CNBC.com News
'The sky is the limit' on Damac investment in the U.S., property giant's chief says
January 09, 2025
Tags
Breaking News: Middle East
Breaking News: Markets
Markets
From
CNBC.com News
Medicare can now cover Eli Lilly’s Zepbound for sleep apnea, CMS says
January 08, 2025
Tags
Biotech and Pharmaceuticals
Companies
LILLY DRN
From
CNBC.com News
Nippon Steel CEO doubles down on pledge to acquire U.S. Steel after suing Biden administration
January 06, 2025
Tags
Companies
Commodity markets
Futures & Commodities
From
CNBC.com News
While Apple negotiates Indonesia sales ban, another Chinese smartphone maker is entering the country
January 06, 2025
Tags
Asia Markets
Market Insider
China Politics
From
CNBC.com News
Biden decides to block Nippon Steel’s $15 billion acquisition of U.S. Steel: Report
January 03, 2025
Tags
Business
Asia Markets
United States Steel Corp
From
CNBC.com News
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
December 24, 2024
Tags
Health care policy
Health care costs
Health & Science
From
CNBC.com News
Honda shares set for best day in more than 16 years on share buyback plan, Nissan deal
December 23, 2024
Tags
Honda Motor Co Ltd
Asia News
Nissan Motor Co Ltd
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
8
9
...
30
31
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.